Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 3-mix-tatin versus calcium hydroxide iodoform for necrotic pulp in primary molars
PACTR201701001868213Not yet recruiting
- Sponsor
- Cairo University
- Start
- Nov 2016
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of calcium hydroxide + iodoform in Pulp necrosis of deciduous tooth (2 arms), sponsored by Cairo University. Primary endpoint: post operative pain. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
calcium hydroxide + iodoform
03
Conditions
Pulp necrosis of deciduous tooth
Beyond the preview
Go deeper on PACTR201701001868213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201701001868213.